Supernus Pharmaceuticals

FTC says patent battle over Parkinson's drug could have 'significant implications' for patients
FTC says patent battle over Parkinson's drug could have 'significant implications' for patients
Endpoints
FTC
Parkinson's Disease
Apokyn
Supernus Pharmaceuticals
Sage Chemical
patents
Flag link:
Working its way through a CRL on lead drug, Supernus taps $150M loan
Working its way through a CRL on lead drug, Supernus taps $150M loan
Endpoints
Supernus Pharmaceuticals
FDA
Parkinson's Disease
SPN-830
Flag link:
FDA spurns Supernus for Parkinson's drug, noting application issues 'across several areas'
FDA spurns Supernus for Parkinson's drug, noting application issues 'across several areas'
Endpoints
Supernus Pharmaceuticals
FDA
Parkinson's Disease
SPN-830
Flag link:
FDA approves expanded indication for Supernus’ Qelbree for ADHD
FDA approves expanded indication for Supernus’ Qelbree for ADHD
Pharmaceutical Business Review
Supernus Pharmaceuticals
Qelbree
ADHD
FDA
Flag link:
Supernus gears up for Q2 Qelbree launch, in time for back-to-school ADHD script season
Supernus gears up for Q2 Qelbree launch, in time for back-to-school ADHD script season
Fierce Pharma
Supernus Pharmaceuticals
Qelbree
ADHD
drug launches
Flag link:
FDA Approves Novel Non-Stimulant Treatment for ADHD
FDA Approves Novel Non-Stimulant Treatment for ADHD
BioSpace
Supernus Pharmaceuticals
ADHD
FDA
pediatric
Qelbree
Flag link:
Supernus Makes a Parkinson’s Play With $300M Deal for US WorldMeds Drugs
Supernus Makes a Parkinson’s Play With $300M Deal for US WorldMeds Drugs
Xconomy
Supernus Pharmaceuticals
US WorldMeds
Flag link:
Supernus Pharmaceuticals seeks FDA approval for ADHD drug
Supernus Pharmaceuticals seeks FDA approval for ADHD drug
Bizjournals
ADHD
FDA
Supernus Pharmaceuticals
SPN-812
Flag link:
The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials, Earnings And IPOs
The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials, Earnings And IPOs
Yahoo/Benzinga
FDA
Novartis
Ascendis
Eiger BioPharmaceuticals
Proteostasis Therapeutics
Fibrocell Science
Supernus Pharmaceuticals
FibroGen
INSYS Therapeutics
Flag link:
As with children studies, Supernus ADHD drug shows fast onset of action in adolescents
As with children studies, Supernus ADHD drug shows fast onset of action in adolescents
Endpoints
Supernus Pharmaceuticals
ADHD
clinical trials
SPN-812
Flag link:
Why Supernus Pharmaceuticals Inc. Is Having a Rather Non-Super Day
Why Supernus Pharmaceuticals Inc. Is Having a Rather Non-Super Day
Motley Fool
Supernus Pharmaceuticals
earnings
Flag link:
Supernus Pharma Tanks on Settlement of Two Patent Disputes
Supernus Pharma Tanks on Settlement of Two Patent Disputes
Investopedia
Supernus Pharmaceuticals
patents
Actavis
Teva Pharmaceutical
Trokendi XR
Flag link:
5 Biotech Stocks Under $10 on the Move
5 Biotech Stocks Under $10 on the Move
TheStreet.com
biotech
Organovo
Supernus Pharmaceuticals
ARCA biopharma
Cerus
Transition Therapeutics
Flag link:
This Week in Biotech
This Week in Biotech
Motley Fool
Supernus Pharmaceuticals
Novartis
Pain Therapeutics
GTx
Flag link:
Supernus Launches Oxtellar XR in the United States
Supernus Launches Oxtellar XR in the United States
Review Seeker
Supernus Pharmaceuticals
Oxtellar XR
epilepsy
Flag link:
Favorable AcelRx Stock Offering Price May Catalyze The Company's Share Price
Favorable AcelRx Stock Offering Price May Catalyze The Company's Share Price
Seeking Alpha
AcelRx
Supernus Pharmaceuticals
Flag link:
Do Oxtellar and Trokendi Make Supernus a Buy?
Do Oxtellar and Trokendi Make Supernus a Buy?
Motley Fool
Oxtellar
Trokendi
Supernus Pharmaceuticals
JNJ
Novartis
Flag link:
Supernus' Shocking Dilution
Supernus' Shocking Dilution
Motley Fool
Supernus Pharmaceuticals
Flag link:
After 2 Drug Approvals, Can Supernus Deliver In 2013?
After 2 Drug Approvals, Can Supernus Deliver In 2013?
Seeking Alpha
Supernus Pharmaceuticals
SPN-810
epilepsy
Oxtellar XR
ADHD
Flag link:
Acadia Pharmaceuticals Poised For 100% Gain By December
Acadia Pharmaceuticals Poised For 100% Gain By December
Seeking Alpha
Acadia
Supernus Pharmaceuticals
pimavanserin
Arena Pharmaceuticals
Parkinson's Disease Psychosis
Flag link:

Pages